0001209191-23-028735.txt : 20230511
0001209191-23-028735.hdr.sgml : 20230511
20230511161531
ACCESSION NUMBER: 0001209191-23-028735
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230509
FILED AS OF DATE: 20230511
DATE AS OF CHANGE: 20230511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kiely John
CENTRAL INDEX KEY: 0001781149
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38485
FILM NUMBER: 23911220
MAIL ADDRESS:
STREET 1: C/O ZOVIO INC
STREET 2: 1811 E NORTHROP BLVD
CITY: CHANDLER
STATE: AZ
ZIP: 85286
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001723128
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
BUSINESS PHONE: (908) 947-3120
MAIL ADDRESS:
STREET 1: 400 CROSSING BOULEVARD
STREET 2: 3RD FLOOR
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Atlas Holdings, Inc.
DATE OF NAME CHANGE: 20171117
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-09
0
0001723128
Amneal Pharmaceuticals, Inc.
AMRX
0001781149
Kiely John
C/O AMNEAL PHARMACEUTICALS, INC.
400 CROSSING BOULEVARD
BRIDGEWATER
NJ
08807
1
0
0
0
0
Class A Common Stock
2023-05-10
4
M
0
80128
A
179274
D
Restricted Stock Units
2023-05-09
4
A
0
76453
0.00
A
Class A Common Stock
76453
76453
D
Restricted Stock Units
2023-05-10
4
M
0
80128
0.00
D
Class A Common Stock
80128
0
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.
On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023.
Exhibit List: Exhibit 24 - Power of Attorney
/s/ Denis Butkovic, Attorney-in-Fact
2023-05-11
EX-24
2
poa.txt
POA DOCUMENT
Exhibit 24
POWER OF ATTORNEY
Know all by these presents that the undersigned, does hereby make, constitute
and appoint Denis Butkovic and Chris Daly as a true and lawful attorney-in-fact
of the undersigned with full powers of substitution and revocation, for and in
the name, place and stead of the undersigned (in the undersigned's individual
capacity), to execute and deliver such forms that the undersigned may be
required to file with the U.S. Securities and Exchange Commission as a result of
the undersigned's ownership of or transactions in securities of Amneal
Pharmaceuticals, Inc. pursuant to Sections 13(d), 13(g) and 16(a) of the
Securities Exchange Act of 1934, as amended, including without limitation,
Schedule 13D, Schedule 13G, Form 3, Form 4 and Form 5 (including any amendments
thereto). The Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Schedule 13D, Schedule 13G, Forms 3, 4
and 5 with regard to his or her ownership of or transactions in securities of
Amneal Pharmaceuticals, Inc., unless earlier revoked in writing. This Power of
Attorney also serves to revoke and replace as of the date hereof, any prior
Power of Attorney executed by the undersigned with respect to the ownership of
securities of Amneal Pharmaceuticals, Inc. The undersigned acknowledges that
Denis Butkovic and Chris Daly are not assuming any of the undersigned's
responsibilities to comply with Section 13 or Section 16 of the Securities
Exchange Act of 1934, as amended.
By: /s/ John Kiely
Name: John Kiely
Date: May 5, 2023